#$%^&*AU2013100533A420130516.pdf#####Abstract The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C2 0-alkylphenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.